Insider Transactions in Q2 2022 at Myomo, Inc. (MYO)
Insider Transaction List (Q2 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 14
2022
|
Thomas Aloysius Crowley Jr. |
SELL
Open market or private sale
|
Direct |
291
-100.0%
|
$291
$1.67 P/Share
|
|
Jun 13
2022
|
Micah Mitchell Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,846
-3.6%
|
$1,846
$1.79 P/Share
|
|
Jun 13
2022
|
David A Henry Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,417
-5.39%
|
$4,417
$1.8 P/Share
|
|
Jun 13
2022
|
Harry Kovelman Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
484
-0.93%
|
$484
$1.83 P/Share
|
|
Jun 10
2022
|
Thomas Aloysius Crowley Jr. |
SELL
Open market or private sale
|
Direct |
6,000
-95.37%
|
$6,000
$1.97 P/Share
|
|
Jun 09
2022
|
Thomas Aloysius Crowley Jr. |
SELL
Open market or private sale
|
Direct |
110
-1.72%
|
$220
$2.15 P/Share
|
|
Jun 08
2022
|
Thomas Aloysius Crowley Jr. |
SELL
Open market or private sale
|
Direct |
3,000
-31.91%
|
$6,000
$2.15 P/Share
|
|
Jun 08
2022
|
David A Henry Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
41,500
+33.6%
|
-
|
|
Jun 08
2022
|
Harry Kovelman Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
28,000
+35.02%
|
-
|
|
Jun 08
2022
|
Micah Mitchell Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
28,000
+35.32%
|
-
|
|
Jun 08
2022
|
Paul R Gudonis Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
75,000
+29.96%
|
-
|
|
Jun 06
2022
|
Thomas Aloysius Crowley Jr. |
SELL
Open market or private sale
|
Direct |
3,500
-27.13%
|
$7,000
$2.29 P/Share
|
|
Jun 03
2022
|
Harry Kovelman Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
138
-0.57%
|
$276
$2.31 P/Share
|
|
May 24
2022
|
David A Henry Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,394
-7.73%
|
$6,788
$2.06 P/Share
|
|
May 24
2022
|
Harry Kovelman Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,849
-10.58%
|
$5,698
$2.06 P/Share
|
|
May 20
2022
|
Paul R Gudonis Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
8,302
+7.64%
|
-
|
|
May 20
2022
|
David A Henry Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
8,297
+15.89%
|
-
|
|
May 20
2022
|
Harry Kovelman Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
6,987
+20.59%
|
-
|
|
May 20
2022
|
Micah Mitchell Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
7,424
+24.18%
|
-
|
|
May 03
2022
|
Harry Kovelman Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
134
-0.67%
|
$402
$3.03 P/Share
|
|
Apr 04
2022
|
Harry Kovelman Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
134
-0.66%
|
$536
$4.01 P/Share
|